EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk

I. M. Wilson, E. A. Vucic, K. S.S. Enfield, K. L. Thu, Y. A. Zhang, R. Chari, W. W. Lockwood, N. Radulovich, D. T. Starczynowski, J. P. Banáth, M. Zhang, A. Pusic, M. Fuller, K. M. Lonergan, D. Rowbotham, J. Yee, J. C. English, T. P.H. Buys, S. A. Selamat, I. A. Laird-OffringaP. Liu, M. Anderson, M. You, M. S. Tsao, C. J. Brown, K. L. Bennewith, C. E. MacAulay, A. Karsan, A. F. Gazdar, S. Lam, W. L. Lam

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Keyphrases